Showing results (101-110 of 129) with videos related to
Sort By:
Pageof 13
European Heart Journal|December 15, 2021
National networking in rare diseases and reduction of cardiac burden in thalassemia majorAlessia Pepe, Laura Pistoia, Maria Rita Gamberini, et al.Journal of Cardiovascular Medicine (Hagerstown, Md.)|June 20, 2015
Myocardial fibrosis by late gadolinium enhancement cardiac magnetic resonance and hepatitis C virus infection in thalassemia major patientsAlessia Pepe, Antonella Meloni, Zelia Borsellino, et al.Hematology (Amsterdam, Netherlands)|February 11, 2016
The Italian multiregional thalassemia registry: Centers characteristics, services, and patients' populationRosa Conte, Lucia Ruggieri, Arianna Gambino, et al.Blood Transfusion = Trasfusione Del Sangue|October 1, 2020
Genotypic groups as risk factors for cardiac magnetic resonance abnormalities and complications in thalassemia major: a large, multicentre studyLaura Pistoia, Antonella Meloni, Paolo Ricchi, et al.British Journal of Haematology|October 18, 2016
The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major-intermedia dichotomy?Angela Vitrano, Giuseppina Calvaruso, Eliana Lai, et al.American Journal of Hematology|May 25, 2012
Long-term use of deferiprone significantly enhances left-ventricular ejection function in thalassemia major patientsAurelio Maggio, Angela Vitrano, Gaetano Lucania, et al.Haematologica|October 2, 2010
Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imagingAlessia Pepe, Antonella Meloni, Marcello Capra, et al.American Journal of Hematology|October 3, 2025
Quantifying Morbidity Risk Attributed to Red-Cell Transfusion Volume in Optimally Transfused Patients With β-ThalassemiaKhaled M Musallam, Angela Vitrano, Alessandro Inzerillo, et al.British Journal of Haematology|August 1, 2025
Impact of lifetime anaemia and iron control on outcomes in β-thalassaemia: Data from the longitudinal de-LIGHT studyKhaled M Musallam, Angela Vitrano, Alessandro Inzerillo, et al.European Journal of Haematology|June 4, 2025
Lifetime Risk of Liver Disease in Patients With β-Thalassemia: Data From the de-LIGHT Retrospective Cohort StudyKhaled M Musallam, Angela Vitrano, Alessandro Inzerillo, et al.Pageof 13